Current Osteoporosis Reports

, Volume 10, Issue 3, pp 217–220

Bone Density Testing Intervals and Common Sense

Evaluation and Management (M Kleerekoper, Section Editor)

DOI: 10.1007/s11914-012-0111-6

Cite this article as:
Lewiecki, E.M. & Binkley, N. Curr Osteoporos Rep (2012) 10: 217. doi:10.1007/s11914-012-0111-6


Measurement of bone mineral density (BMD) is underutilized, contributing to the underdiagnosis and undertreatment of osteoporosis. Appropriate patient selection for BMD testing leads to more people being treated, fewer fractures, and a decrease in fracture-related health care costs. Although there are well-established indications for BMD testing, it is less clear when a BMD test should be repeated for a patient who does not have osteoporosis and is found to be at low fracture risk with initial testing. BMD testing intervals should be individualized according to the likelihood that the results will influence treatment decisions.


OsteoporosisScreeningFrequencyIntervalBone density testing

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.New Mexico Clinical Research & Osteoporosis CenterAlbuquerqueUSA
  2. 2.University of WisconsinMadisonUSA